Navigation Links
invivodata Recognized as One of Pittsburgh's Fastest Growing Private Companies
Date:8/25/2008

Pittsburgh Business Times Names invivodata to 2008 Pittsburgh 100

PITTSBURGH, Aug. 25 /PRNewswire/ -- invivodata inc., the industry leader in electronic patient reported outcomes (ePRO) solutions and services for global clinical research, today announced that the Pittsburgh Business Times has recognized the company in the "2008 Pittsburgh 100" annual ranking of the fastest-growing, privately-held companies in Western Pennsylvania.

"We see the Pittsburgh 100 as one of the most important lists we publish," said Alan Robertson, publisher of the Pittsburgh Business Times. "The companies on this list represent many industries and many geographic locations around the region. The Pittsburgh 100 companies also represent all different sizes of companies, from small firms to multi-billion dollar operations. We see the Pittsburgh 100 as proof that the region remains a vibrant, growth-oriented business environment."

Rankings on the list were based on the rate of growth from 2005 through 2007. Honored at an awards program at the Duquesne Club in downtown Pittsburgh on August 21, invivodata was ranked the 10th fastest-growing technology company and #43 overall on the list of 100, based on revenue growth.

"We're very proud to be included in the Pittsburgh 100," said Doug Engfer, invivodata president and CEO. "We believe our inclusion in the list is representative of the consistent results we are delivering to our new and existing customers, and the growing demand for our ePRO solutions and expertise."

About invivodata inc.

invivodata combines behavioral science, information technology, and clinical research expertise to capture high quality clinical trial data directly from patients. invivodata's electronic Patient Reported Outcomes (ePRO) solutions, which are based on over 20 years of research, deliver reliable patient self-reported data by driving patient compliance with the protocol and eliminating recall biases that plague paper-based self-report data. invivodata's solutions include comprehensive trial-support services that facilitate the collection of ePRO data, and web-based access to study data and operational reports that give researchers and sponsors visibility into study progress and improve trial efficiencies. invivodata's solution has been used in more than 200 trials and is the industry-leading ePRO system in delivering primary efficacy data for FDA drug approvals. invivodata inc. is a privately held company with global headquarters in Pittsburgh, Pa., USA; its European headquarters is in London, England; and its technology development center is in Scotts Valley, Calif., USA. For more information visit http://www.invivodata.com/.

For more information, contact:

invivodata inc.

Christine Tobin

Corporate Communications Specialist

(412) 390-3000, ext. 3502

ctobin@invivodata.com


'/>"/>
SOURCE invivodata inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Vigilan Recognized as One of the Fastest-Growing Private Companies in the U.S.
2. Waters SYNAPT HDMS and Xevo TQ MS Recognized for Mass Spectrometry Innovation by Industry Experts
3. Covance Recognized for Outstanding Performance by Merck & Co., Inc.
4. Covance Recognized for Outstanding Customer Service by Eli Lilly and Company
5. Nationally Recognized Pediatric Healthcare System Chooses PureWellness for Employee Wellness Program
6. STAAR Surgicals Collamer(R) IOL and Elastimide(R) IOL Each Recognized with New Technology Intraocular Lens Classification
7. Dr. Emil Chynn Featured on FOX News (WNYW-TV) Park Avenue Laser Vision Center Recognized for Creative Internet Marketing
8. Creator of PubMed Central biomedical research database recognized for outstanding citizen service
9. Verathon Inc., Recognized, Second Year Running, as Outstanding Workplace in Washington State by Washington CEO Magazine
10. China Sky One Medical, Inc. Research Center Recognized by Heilongjiang Science and Technology Institute
11. N.Y. Mets Omar Minaya Recognized at National Brain Cancer Organizations 3rd Annual Gala
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2017)... ... 19, 2017 , ... Bone Solutions Inc. (BSI), an orthobiologics ... medical device, OsteoCrete®. OsteoCrete® bone void filler is designed to assist with bone ... a critical property for bone health and development. , “We’re excited to bring ...
(Date:9/19/2017)... ... September 19, 2017 , ... Premiere Long Island dental office Gold ... named one of the best dentists in America under age 40 by Incisal Edge ... Every fall, the magazine features the best 40 dentists under the age of 40 ...
(Date:9/19/2017)... ... 19, 2017 , ... Inc. magazine ranked Endo-Systems ... the nation's fastest-growing private companies. The list represents a unique look at the ... and midsized businesses. Endo-Systems is a leading B2B distributor of today’s most scientifically ...
(Date:9/18/2017)... , ... September 18, 2017 , ... TransLuma is a set of dissolving transitions created ... dissolve in or dissolve away the luminance of a scene without the use of keyframes. ... next scene before fully transitioning over. , TransLuma allows editors to gradually dissolve away the ...
(Date:9/18/2017)... CA (PRWEB) , ... September 18, 2017 , ... Cosmetic ... on its website. According to the senior editor of Cosmetic Tow, “Our forum section ... as well as provide answers to other forum members thinking about having cosmetic surgery. ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017  Consumer reviews on the independent ... as the number one company for hearing aids, ranking it ... fifteen other brands. ... Hearing Named #1 by Consumers For Hearing Aids ... Embrace Hearing is an online store that provides high performance, ...
(Date:9/9/2017)... WASHINGTON , Sept. 8, 2017 ... Mobile MRI Unit coming to Washington DC ... When: Tuesday, September 12 th – Monday, ... to Washington, D.C. offering free MRI brain scans to the public.Where:  ... – will be parked at 501 K Street NW, Washington, D.C.What:BTF brings ...
(Date:9/9/2017)... 2017  Eli Lilly and Company (NYSE: ... data for lasmiditan, an investigational, oral, first-in-class molecule for ... improvements compared to placebo in the Phase 3 SPARTAN ... 18th Congress of the International Headache Society (IHC) in ... presented today demonstrate lasmiditan,s potential to reduce pain and ...
Breaking Medicine Technology: